In which month should seasonal influenza vaccination be discontinued in the Northern Hemisphere?

When to Stop Offering Flu Vaccine in the Northern Hemisphere

Do not stop offering influenza vaccine in the Northern Hemisphere until June 30th, as vaccines should be administered throughout the entire influenza season as long as influenza viruses are circulating and unexpired vaccine is available. 1

Key Timing Principles

The influenza season in the Northern Hemisphere is highly unpredictable, with substantial variability in both onset and duration that makes setting an arbitrary stop date inappropriate for optimal patient protection.

Seasonal Activity Patterns

• Peak activity typically occurs January through March, but influenza circulation can extend well into late spring (May or later), with one or more disease peaks possible in a single season 1
• Historical data from 1976-2008 shows that peak influenza activity occurred in March in 30% of years, April in 25% of years, and May in 20% of years 1
• The 2021-2022 season demonstrated late-season activity extending into May with multiple peaks 1

Official Guideline Recommendations

The AAP and CDC explicitly state that vaccination efforts should continue throughout the entire influenza season, including after influenza activity has been documented in the community. 1

Key guideline points include:

• Continue vaccinating as long as influenza viruses are circulating and unexpired vaccine is available 1
• All influenza vaccines in the United States are labeled with expiry dates of June 30 of the influenza season, establishing this as the practical endpoint 1
• Vaccine administered in December or later, even after influenza activity has begun, is likely beneficial in the majority of seasons 1

Clinical Rationale for Continued Vaccination

Protection Despite Late Vaccination

• Adults develop antibody protection within 2 weeks of vaccination, making late-season vaccination still protective 1
• Even individuals who have already had influenza during the current season should be offered vaccination, as the vaccine may protect against other circulating strains 1

Risk of Missed Opportunities

Stopping vaccination prematurely creates missed opportunities that cannot be recovered, as patients may not return for vaccination and the unpredictable nature of influenza seasons means late peaks can occur 1

Duration of Protection

While some waning of vaccine effectiveness occurs over time (approximately 7-9% per month for certain strains), vaccine effectiveness remains greater than zero for at least 5-6 months after vaccination 1

Common Pitfalls to Avoid

• Do not arbitrarily stop offering vaccine in March or April based on typical peak timing, as substantial influenza activity frequently occurs after these months 1
• Do not refuse vaccination to patients presenting in late winter or spring, as they will still benefit from protection during the remainder of the season 1
• Do not assume the season is over based on local activity patterns, as influenza circulation varies by community and region 1

Practical Implementation

Continue routine vaccination offers at all healthcare visits through June 30th, maintaining vaccine availability throughout this period 1

The only practical endpoint is June 30th, when vaccines expire, at which point the current season's formulation is no longer valid and next season's vaccine should be awaited 1